Physician profile
Srinivasan Devanathan
NPI 1104874452
$4,670.54
in general payments reported to CMS, 2019-2025
13 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.88 · 2020: $16.07 · 2021: $31.24 · 2022: $2,785 · 2023: $744 · 2024: $874 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.70 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $2,817.55 | 2022-2024 | |
| Inspire Medical Systems, INC. | $1,336.23 | 2022-2025 | Inspire |
| Zoll Respicardia, INC. | $155.52 | 2024 | Remede System |
| Harmony Biosciences LLC | $103.51 | 2021-2024 | Wakix |
| Fisher & Paykel Healthcare INC | $51.32 | 2022-2024 | Fisher & Paykel Healthcare |
| Glaxosmithkline, LLC. | $36.94 | 2019 | |
| Axsome Therapeutics, INC. | $36.55 | 2023 | Sunosi |
| Resmed Corp | $34.37 | 2020-2024 | |
| Mallinckrodt Hospital Products INC. | $29.90 | 2024 | Acthar |
| Itamar Medical INC | $23.22 | 2024 | Watchpatone |
| Philips North America LLC | $17.49 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.53 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivasan Devanathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.